SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Reid Hoffman, a Board member since 2017, informed Microsoft on June 2, 2026 that he will not stand for re-election at the 2026 annual shareholder meeting. Although he will remain in office until the Annual Meeting, the principal disclosed action is his departure from the Board. Board-level departures at major public companies are material to investors assessing governance and continuity.
View raw filing on EDGAR →The filing discloses multiple unregistered private placements of equity securities to accredited investors and independent directors under Section 4(a)(2) and Regulation D Rule 506(c), totaling approximately $1.58 million in aggregate proceeds across Class E, Class A-I, and Class A-II common stock. This is a classic dilutive issuance disclosure under Item 3.02, material to investors assessing ownership dilution and capital-raising activity.
View raw filing on EDGAR →The filing discloses a press release announcing a monthly cash distribution to unitholders, filed under Item 2.02 (Results of Operations and Financial Condition). While this is a routine distribution announcement rather than a full earnings release, it is material to unitholders as it communicates the registrant's cash generation and distribution capacity. The press release is attached as Exhibit 99.1 and incorporated by reference, consistent with earnings-related disclosures.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from GTJ REIT's Annual Meeting of Stockholders held on June 4, 2026, covering the election of three Class II directors (Paul Cooper, Louis Sheinker, and Stanley Perla) and ratification of Baker Tilly US, LLP as independent auditor. The filing directly matches Item 5.07 requirements and presents vote tallies for each proposal, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →Goldman Sachs Real Estate Finance Trust renewed its advisory agreement with Goldman Sachs Asset Management, L.P. for an additional one-year period effective June 10, 2026, continuing the existing advisory relationship with no substantive changes to terms.
View raw filing on EDGAR →The company completed an unregistered private placement of Class I and Class S common stock totaling approximately $10.8 million in aggregate consideration pursuant to Section 4(a)(2) and Regulation D, diluting existing shareholders' ownership.
View raw filing on EDGAR →The company disclosed routine monthly distributions to shareholders and two significant loan originations totaling $186 million in new mortgage lending activity: a $53.0 million Durham Multifamily loan and a $133.0 million Chicago Multifamily loan, representing material operational activity for the real estate finance trust.
View raw filing on EDGAR →Fortress Net Lease REIT issued and sold approximately 10.9 million common shares for gross proceeds of $113.6 million on June 1, 2026, pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions from registration.
View raw filing on EDGAR →Fortress Net Lease REIT declared distributions on May 29, 2026, with varying net distributions per share across six share classes ranging from $0.0547 to $0.0729 gross, affecting shareholder returns.
View raw filing on EDGAR →Fortress Credit Realty Income Trust completed an unregistered sale of 994,813 common shares across multiple share classes for approximately $20.0 million in gross proceeds, conducted pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions.
View raw filing on EDGAR →The filing discloses an unregistered sale of 613,712 common shares of beneficial interest for approximately $12.6 million under Section 4(a)(2) and Regulation D Rule 506. This is a classic dilutive private placement by a non-traded REIT raising capital through exempt offerings, which materially affects shareholder equity and voting power.
View raw filing on EDGAR →Assembly Biosciences held its Annual Meeting of Stockholders on June 4, 2026, with shareholders voting on five proposals: election of nine directors, advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as auditor, and approval of amendments to the 2018 Stock Incentive Plan and ESPP to increase reserved shares.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder meeting results held on June 3, 2026. The filing reports voting outcomes on four proposals: election of 11 directors, advisory vote on executive compensation, ratification of Deloitte & Touche LLP as auditor, and a shareholder proposal on written consent rights. The detailed vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal are the core content of the filing.
View raw filing on EDGAR →The disclosure centers on the Board's approval and grant of 4,060,000 performance share units to Daniel Tassé, the CEO, pursuant to the newly adopted DBV Technologies 2026 Performance Share Unit Plan. This is a compensatory arrangement for a named executive officer involving equity grants with performance and employment conditions, which is the core subject matter of Item 5.02(e). While the filing also references shareholder authorization and plan adoption, the principal disclosed action is the grant of PSUs to the CEO, making this an executive compensation event that would materially affect investor assessment of the company's incentive structure and CEO alignment.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Cardinal Infrastructure Group's 2026 Annual Meeting of Stockholders held on June 5, 2026. The filing reports the results of two proposals: (1) election of six directors with detailed vote tallies for each nominee, and (2) ratification of Grant Thornton LLP as independent auditor. Item 5.07 explicitly requires disclosure of shareholder vote results, and all directors and the auditor were approved by substantial majorities, making this a material governance event.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from the Annual Meeting of Shareholders held on June 3, 2026. The filing presents detailed voting tallies for three proposals: (i) election of ten directors, (ii) ratification of Deloitte & Touche LLP as independent auditor, and (iii) advisory vote on named executive officer compensation. All three proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and audit oversight.
View raw filing on EDGAR →Mark A. Alexander's resignation from the Board of Directors of Builders FirstSource, Inc., effective immediately on June 3, 2026, constitutes a director departure. The filing explicitly states the resignation was due to health reasons and clarifies there was no disagreement with the Company. Director changes are material events affecting the composition and governance of the registrant.
View raw filing on EDGAR →The Board approved base salaries and target bonuses for four named executive officers (CEO, CFO, CTO, COO) following the company's business combination closing. This is a compensatory arrangement disclosure under Item 5.02(e), establishing initial compensation structures with specific salary amounts and bonus percentages. The disclosure is material as it establishes executive compensation post-merger and would affect investor assessment of the company's cost structure and executive incentives.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from McGrath RentCorp's June 3, 2026 annual meeting, covering four proposals: director elections, stock incentive plan amendment, auditor ratification, and executive compensation approval. The filing presents vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the defining characteristic of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →The Company terminated three material financing arrangements totaling approximately $57.8 million, including elimination of $56.0 million in term debt, a convertible note indenture, and an equity line, representing a significant restructuring of the Company's capital structure and financial obligations.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Outset Medical's Annual Meeting of Stockholders held on June 4, 2026. The filing presents voting results for three proposals: election of Class III directors (Brent D. Lang and Karen Prange), advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals passed with clear majorities, and the disclosure includes vote counts (For, Against, Abstain, Broker Non-Votes) for each matter.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Definitive Healthcare's 2026 Annual Meeting of Stockholders held on June 4, 2026. The filing presents voting results for four proposals: election of three Class II directors, ratification of Deloitte & Touche LLP as independent auditor, approval of a 15-million-share increase to the 2021 Equity Incentive Plan, and an advisory vote on named executive officer compensation. All proposals passed with substantial majorities, and the disclosure includes detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal as required by SEC rules.
View raw filing on EDGAR →BrightSpring entered into an underwriting agreement for a secondary offering of 14,999,771 shares at $58.75/share by existing stockholders (KKR Phoenix Aggregator and Management Selling Stockholders), with the Company repurchasing 1,026,465 shares. While this is technically a secondary offering (not a primary issuance by the Company), the Company's share repurchase activity and the substantial equity transaction involving ~15 million shares would materially affect investor assessment of capital structure and ownership dilution.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Sana Biotechnology's 2026 annual meeting held on June 4, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors (Hans E. Bishop, Robert Nelsen, and Alise S. Reicin, M.D.) and (2) ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (For, Against/Withheld, Abstain, and Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →Gladstone Capital entered into an underwriting agreement on June 3, 2026, for a registered direct offering of $60.0 million in 7.000% Notes due 2029, with closing on June 5, 2026. While this is technically a debt issuance rather than an equity issuance, the disclosure is material to investors as it represents a significant capital raise that increases the company's leverage and financial obligations. The company intends to use proceeds to repay credit facility debt and fund investments, which affects the capital structure and investor risk profile. This is classified as dilutive_issuance as the closest match in the taxonomy for material capital-raising activities, though the event could also be characterized as a material debt financing under other_material.
View raw filing on EDGAR →FMC Corporation completed a $1.2 billion private offering of senior secured notes on June 5, 2026, a material financing transaction intended to refinance existing debt and support general corporate purposes.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Sight Sciences' June 4, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: election of two Class II directors (Gerhard Burbach and Staffan Encrantz) and ratification of Deloitte & Touche LLP as independent auditor. The disclosure includes vote tallies, quorum information (76.2% attendance), and explicit statement that both proposals passed. This is a textbook Item 5.07 shareholder vote results disclosure, material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from KinderCare's 2026 Annual Meeting of Stockholders held on June 4, 2026. The filing reports voting outcomes on three proposals: election of directors (Michael Nuzzo, John T. Wyatt, and Jean Desravines), ratification of PwC as independent auditor, and advisory approval of named executive officer compensation. All proposals passed with substantial majorities, and the disclosure includes vote tallies (For/Against/Withhold/Abstain/Broker Non-Votes) for each matter, which is the hallmark of Item 5.07 shareholder vote results reporting.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Harmonic Inc.'s 2026 Annual Meeting held on June 4, 2026. The filing reports voting outcomes on five matters: election of seven directors, advisory approval of named executive officer compensation, frequency of future say-on-pay votes, amendment to the 2025 Equity Incentive Plan, and ratification of Ernst & Young LLP as independent auditor. All matters were approved by stockholders. This is material as it reflects stockholder governance decisions and approval of executive compensation and equity plan amendments.
View raw filing on EDGAR →3D Systems completed a registered public offering of 16.4 million shares at $3.05 per share, raising approximately $50 million in gross proceeds, with an additional 2.5 million share overallotment option granted to underwriters. This is a material registered equity issuance that dilutes existing shareholders and materially affects the company's capital structure and equity base.
View raw filing on EDGAR →Claros Mortgage Trust held its Annual Meeting on June 3, 2026, with stockholders voting on four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, and approval of amendments to the 2016 Incentive Award Plan. The amendments increase the share reserve by 6.5 million shares, expand ISO grants, extend the ISO grant period, and establish a $750,000 annual compensation cap for non-employee directors.
View raw filing on EDGAR →Terence J. Voskuil, Executive Vice President and Chief Technology Officer, Aerospace, notified the company on June 2, 2026 of his intention to retire effective October 2, 2026. This is a clear executive departure of a named officer at the C-suite level, and the departure of a CTO in a technology-dependent aerospace company would materially affect investor assessment of the registrant's leadership and technical direction.
View raw filing on EDGAR →This is a Form 8-K Item 5.07 disclosure of shareholder voting results from the June 4, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies for three matters: (1) election of seven directors, (2) advisory vote on named executive officer compensation, and (3) ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities. This is a routine but material disclosure required by Item 5.07 of Form 8-K.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the results of QuantumScape's 2026 Annual Meeting of Stockholders held on June 3, 2026, including voting outcomes for three proposals: (1) election of ten directors, (2) ratification of Ernst & Young LLP as independent auditor, and (3) non-binding advisory approval of named executive officer compensation. The detailed vote tallies (votes for, against, withheld, abstentions, and broker non-votes) for each director and proposal are the core disclosure, which is the standard format for shareholder vote results under Item 5.07.
View raw filing on EDGAR →Universal Insurance Holdings amended its 5.625% Senior Unsecured Notes indenture on June 3, 2026, with majority noteholder consent. The amendments shorten the redemption notice period from 30 days to 5 days and permit conditional redemption notices, providing "greater operational flexibility" for redemption. While this is a material debt modification affecting the Company's $XXX million in outstanding notes, it does not fit cleanly into the covenant_breach or dilutive_issuance categories—it is a negotiated amendment to existing debt terms, not a breach or new issuance. The materiality stems from the modification of significant debt obligations and the Company's apparent intent to exercise redemption flexibility.
View raw filing on EDGAR →AEVEX Corp. entered into an underwriting agreement on June 3, 2026, to conduct a registered public offering of 5,726,157 shares of Class A Common Stock at $27.00 per share, with an additional 858,923 shares available under a 30-day option. This is a material registered equity issuance that dilutes existing shareholders and raises capital through the sale of newly issued securities, fitting the dilutive_issuance category. The offering closed on June 5, 2026, with Goldman Sachs, BofA Securities, and Jefferies as underwriters.
View raw filing on EDGAR →J.Jill held its 2026 Annual Meeting on June 3, 2026, at which shareholders voted on the election of two Class III directors (Michael Rahamim and Mary Ellen Coyne) and the ratification of Grant Thornton LLP as independent auditor. The filing discloses the voting tallies for each proposal.
View raw filing on EDGAR →Andrew Rolfe retired from the Board of Directors, resulting in a reduction in board size. This departure is material to investors assessing governance structure and board effectiveness.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Firefly Aerospace's June 4, 2026 annual meeting, including election of directors (Jason Kim and Kevin McAllister) and ratification of Grant Thornton LLP as independent auditor. Item 5.07 explicitly requires disclosure of shareholder vote results, and these outcomes are material to investors as they confirm board composition and auditor appointment for the fiscal year.
View raw filing on EDGAR →Plus Therapeutics entered into an Equity Distribution Agreement with Canaccord Genuity to conduct an at-the-market (ATM) offering of up to $17,350,000 in common stock. This is a dilutive equity issuance under an ATM arrangement, which is a classic signal of capital raising at small- and mid-cap issuers. The company intends to use net proceeds for general corporate purposes and working capital, indicating potential financial stress or liquidity needs.
View raw filing on EDGAR →The filing discloses compensatory arrangements for named executive officers and non-employee directors, including: (1) renewal and amendment of the Annual Long-Term Incentive Award Plan with specific RSU and PSU grants to Matthew Malone, Daniel J. Thoren, and Christopher J. Thome; (2) amendment of the Annual Executive Cash Bonus Program with target bonus levels ranging from 50% to 100% of base salary; and (3) annual RSU grants to six non-employee directors. These are classic executive compensation disclosures under Item 5.02(e), material to investors assessing executive incentive structures and equity dilution.
View raw filing on EDGAR →Falcon's Attractions (a subsidiary) entered into a Master Consulting Services Agreement valued at approximately $10.6 million to provide master plan design consulting services for a theme park in Arizona. While this is a material contract for a design consulting company, it does not fit neatly into the standard 8-K event taxonomy (not M&A, not an earnings release, not an executive change, etc.). The materiality threshold and revenue significance warrant disclosure, but the event is best classified as other_material given the absence of a more specific category.
View raw filing on EDGAR →Thomas C. Chubb, III resigned from the Board of Flowers Foods, Inc. effective immediately on June 4, 2026, citing competing professional demands as chairman, president and CEO of Oxford Industries. The disclosure emphasizes his six years of service and leadership roles including independent presiding director and chair of the Nominating/Corporate Governance Committee, making this a material departure of a senior director.
View raw filing on EDGAR →The filing discloses awards of Restricted Stock Units (RSUs) to three named executive officers—David A. Hedges (2,078 RSUs), W. James Walker, IV (1,207 RSUs), and Robert L. Smith (1,190 RSUs)—approved by the Compensation Committee on June 5, 2026 under the Company's 2024 Equity and Incentive Compensation Plan. This is a compensatory arrangement for named executives involving equity grants with specified vesting schedules and terms, which is the core definition of exec_compensation under Item 5.02(e).
View raw filing on EDGAR →Alphabet completed a registered public offering of 335 million mandatory convertible preferred depositary shares (167.5 million Series A and 167.5 million Series B), with underwriters exercising over-allotment options for an additional 50 million shares (25 million of each series), closing on June 5, 2026. The shares will convert to Class A Common Stock and Class C Capital Stock upon maturity, creating significant dilution to existing shareholders, with capped call transactions entered into to hedge conversion risk.
View raw filing on EDGAR →Alphabet filed Certificates of Designations establishing Series A and Series B Preferred Stock with material rights modifications, including dividend restrictions on junior stock, mandatory conversion features with price-based conversion rates, and liquidation preferences that establish new senior securities with preferential rights.
View raw filing on EDGAR →Red Violet held its 2026 Annual Meeting of Stockholders on June 3, 2026, with voting results on three matters: election of directors (with specific vote tallies for each nominee), ratification of Grant Thornton as independent auditor, and advisory approval of executive compensation.
View raw filing on EDGAR →EverQuote held its 2026 Annual Meeting of Stockholders, at which shareholders elected seven directors (David Blundin, Sanju Bansal, Paul Deninger, Jayme Mendal, George Neble, John Shields, and Mira Wilczek), approved an amendment to the Certificate of Incorporation to add officer exculpation provisions under Delaware law, and ratified PricewaterhouseCoopers LLP as the independent auditor.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on June 3, 2026, filed under Item 5.07. The section presents final voting tallies for three proposals: election of eight directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of executive compensation. All proposals were approved, with detailed vote counts provided for each nominee and proposal.
View raw filing on EDGAR →Brown & Brown entered into a Third Amended and Restated Credit Agreement on June 5, 2026, materially restructuring its financing arrangements by increasing the revolving credit facility from $800 million to $1,250 million, extending maturity to June 5, 2031, and adding $500 million in new term loan facilities. This material refinancing transaction affects the company's capital structure and liquidity position.
View raw filing on EDGAR →